Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 26, 2023

Elite Labs Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for ELITE LABS INC, and what generic and branded alternatives to ELITE LABS INC drugs are available?

ELITE LABS INC has thirteen approved drugs.

Summary for Elite Labs Inc

US Patents:	0
Tradenames:	8
Ingredients:	8
NDAs:	13

Drugs and US Patents for Elite Labs Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Elite Labs Inc	TRIMIPRAMINE MALEATE	trimipramine maleate	CAPSULE;ORAL	077361-002	Aug 2, 2006	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Elite Labs Inc	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	040227-001	Jun 18, 1997		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Elite Labs Inc	PHENDIMETRAZINE TARTRATE	phendimetrazine tartrate	TABLET;ORAL	040762-001	Jan 28, 2008	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
Elite Labs Inc	DANTROLENE SODIUM	dantrolene sodium	CAPSULE;ORAL	076686-002	Oct 24, 2005	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Elite Labs Inc	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	TABLET;ORAL	040190-001	May 30, 1997	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
Elite Labs Inc	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	212037-001	Dec 11, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

McKinsey

Express Scripts

Mallinckrodt

Johnson and Johnson

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.